EUVIMEDEUVIMED entdecken
Crossref

GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway

Shuangshuang Yang, Yixian Liu iD, Bushi Zhang, Jinxia Li, Fang Xu, Mengdan Yu, Ying Chen, Chenglong Li, Ting Liu, Ying Zhao, Qianwei Zhao, Jintao Zhang

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Shuangshuang Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Cell Proliferation. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsCell ProliferationProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionHumansMiceAnimalsMice, NudeCell MovementNeoplasm MetastasisCell Line, TumorMaleGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysMice, Inbred BALB C

Stichwörter der Autor:innen

GRHPRhepatocellular carcinomametastasismiR-138-5pproliferation

Substanzen

MicroRNAsMIRN138 microRNA, humanProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
  • Henan Key Medical Laboratory of Tumor Molecular Biomarkers, Zhengzhou University, Zhengzhou, China.
  • School of Basic Medical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China.
  • Zhengzhou Railway Vocational and Technical College, Zhengzhou, China.
  • Henan Key Laboratory of Tumor Epidemiology and State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Yixian Liu

Zitieren

APA

Yang, S., Liu, Y., Zhang, B., Li, J., Xu, F., Yu, M., Chen, Y., Li, C., Liu, T., Zhao, Y., Zhao, Q., & Zhang, J. (2024). GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0018

Vancouver

Yang S, Liu Y, Zhang B, Li J, Xu F, Yu M, et al. GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0018

BibTeX
@article{Yang2024,
  author = {Yang, Shuangshuang and Liu, Yixian and Zhang, Bushi and Li, Jinxia and Xu, Fang and Yu, Mengdan and Chen, Ying and Li, Chenglong and Liu, Ting and Zhao, Ying and Zhao, Qianwei and Zhang, Jintao},
  title = {GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0018}
}
Kostenlos starten →